PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Merit Medical Systems, Inc.
- Study ID
- NCT06422871
- Status
- Recruiting
Conditions
- End Stage Renal Disease
- Hemodialysis Access Failure
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- HeRO® Graft System or Super HeRO® System — DEVICETreatment attempted with the HeRO® or Super HeRO® device.
Study Details
The goal of this observational study is to increase the understanding of the safety and performance of Merit Medical's HeRO Graft System (HeRO) and Super HeRO Adaptor and Support Seal System (Super HeRO) devices. This study includes adults that are being treated with one of these devices as part of their regular medical care for maintaining long-term dialysis access when all other dialysis access options have failed. If participants in the study are not seen for a standard of care clinic visit during the 4 visit timepoints over 2 years, the participant will be followed by phone to check their current health and dialysis status.
Key Dates
- Start date
- Jul 28, 2025
- Status verified
- May 2026
- Primary completion
- Jun 28, 2027
- Completion
- Dec 28, 2028
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: HeRO® / Super HeRO®Subjects who meet all inclusion criteria and none of the exclusion criteria and treatment is attempted with the HeRO® Graft or Super HeRO® device.
Primary Outcome Measure
Composite Endpoint [ Time Frame: 6 months ]
Central Contacts
- Hannah Susmeyer978-758-6166
- Vicky Brunk, RN717-873-3309
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | - |
| Sarasota Memorial Health Care System | Sarasota | Florida | 34239 | - |
| WakeMed | Raleigh | North Carolina | 27610 | - |
| University Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15219 | - |
| Baylor Scott & White Heart and Vascular Hospital - Dallas | Dallas | Texas | 75226 | - |
| Houston Methodist Hospital | Houston | Texas | 77030 | - |
| Sentara Norfolk General Hospital | Norfolk | Virginia | 23507 | - |
Find similar trials in Washington D.C., DC
By research site
Related Studies
- Blood Pressure Slopes and Ultrafiltration in Hemodialysis PatientsRecruiting · VA Office of Research and Development · Dallas, Texas
- AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous AnastomosesPHASE1 · Recruiting · Houssam Farres, M.D. · Jacksonville, Florida
- Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on HemodialysisEARLY_PHASE1 · Recruiting · The University of Texas Health Science Center at San Antonio · San Antonio, Texas
- SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas StudyRecruiting · VenoStent · Bullhead City, Arizona